Make a note of our new URL, www.hivmedicinejournal.com!
HIV Medicine
Edited by:
Brian Gazzard and Jens Lundgren
ISI Journal Citation Reports® Ranking: 2008: 15/51 Infectious Diseases
Impact Factor: 3.103
A recently-launched peer-reviewed journal publishing original articles, reviews and guidelines on all aspects of HIV treatment and diagnosis. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
TopNews and Announcements
Free Access in the Developing World
Free online access to this journal is available within institutions in the developing world through the HINARI initiative with the World Health Organization (WHO).
NIH Public Access Mandate
For those interested in the Wiley-Blackwell policy on the NIH Public Access Mandate, please visit our policy statement.
TopHighlights
Read these top cited 2007 articles from HIV Medicine FREE online
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
SR Penzak, G Kabuye, P Mugyenyi, F Mbamanya, V Natarajan, RM Alfaro, C Kityo, E Formentini and H Masur
HIV Medicine, 2007: 8 (2); 86-91
Experience with the use of a first-line regimen of stavudine, lamivudine and nevirapine in patients in the TREAT Asia HIV Observational Database
J Zhou, NI Paton, R Ditangco, Y-MA Chen, A Kamarulzaman, N Kumarasamy, CKC Lee, PCK Li, TP Merati, P Phanuphak, S Pujari, A Vibhagool, F Zhang, J Chuah, KR Frost, DA Cooper, MG Law
HIV Medicine, 2007: 8 (1); 8-16
Relative antiviral efficacy of ritonavir-boosted darunavir and ritonavir-boosted tipranavir vs. control protease inhibitor in the POWER and RESIST trials
A Hill, G Moyle
HIV Medicine, 2007: 8 (4); 259-264
A randomized placebo-controlled trial of metformin for the treatment of HIV lipodystrophy
R Kohli, A Shevitz, S Gorbach, C Wanke
HIV Medicine, 2007: 8 (7); 420-426
Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells
MA French, NM Keane, EJ McKinnon, S Phung, P Price
HIV Medicine, 2007: 8 (3); 148-155
A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection
M Youle, M Osio
HIV Medicine, 2007: 8 (4); 241-250
Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area
E Martínez, A Milinkovic, E Buira, E de Lazzari, A León, M Larrousse, M Loncá, M Laguno, JL Blanco, J Mallolas, F García, JM Miró, JM Gatell
HIV Medicine, 2007: 8 (4); 251-258
Community-based rapid HIV testing in homeless and marginally housed adults in San Francisco
JB Buchér, KM Thomas, D Guzman, E Riley, N Dela Cruz, DR Bangsberg
HIV Medicine, 2007: 8 (1); 28-31
Safety of nevirapine in pregnancy
U Natarajan, A Pym, C McDonald, P Velisetty, SG Edwards, P Hay, J Welch, A de Ruiter, GP Taylor, J Anderson
HIV Medicine, 2007: 8 (1); 64-69
Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women
N Phanuphak, T Apornpong, S Teeratakulpisarn, S Chaithongwongwatthana, C Taweepolcharoen, S Mangclaviraj, S Limpongsanurak, T Jadwattanakul, P Eiamapichart, W Luesomboon, A Apisarnthanarak, A Kamudhamas, A Tangsathapornpong, C Vitavasiri, N Singhakowinta, V Attakornwattana, R Kriengsinyot, P Methajittiphun, K Chunloy, W Preetiyathorn, T Aumchantr, P Toro, EJ Abrams, W El-Sadr, P Phanuphak
HIV Medicine, 2007: 8 (6); 357-366
